Loading...
XSHG
603139
Market cap308mUSD
Dec 05, Last price  
21.81CNY
1D
0.00%
1Q
-6.11%
IPO
-5.50%
Name

Shaanxi Kanghui Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:603139 chart
P/E
P/S
3.88
EPS
Div Yield, %
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
5.42%
Revenues
562m
-16.54%
276,820,956328,064,455375,731,468379,785,070381,845,771367,057,156375,618,264431,421,291414,071,702442,756,905491,511,206672,960,241561,634,852
Net income
-90m
L+242.62%
40,398,48855,822,17662,741,93862,205,19365,234,11263,019,58655,629,18142,763,04234,113,73036,481,4660-26,158,640-89,625,540
CFO
37m
16,119,75639,351,30022,724,63728,502,79671,718,35743,597,45862,635,269107,525,83993,722,9697,418,78850,434,200037,294,171
Dividend
Jun 29, 20220.074 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.
IPO date
Apr 21, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT